These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10680040)

  • 1. Targeting treatment for optimal outcome.
    Husted SE
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I18-22. PubMed ID: 10680040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era.
    Boden WE
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):113S-122S. PubMed ID: 12644349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin as a bridge to timely revascularization in unstable coronary artery disease -- an update of the Fragmin during Instability in Coronary Artery Disease II Trial.
    Wallentin L
    Haemostasis; 2000; 30 Suppl 2():108-13; discussion 106-7. PubMed ID: 11251353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.
    Morrow DA; Cannon CP; Rifai N; Frey MJ; Vicari R; Lakkis N; Robertson DH; Hille DA; DeLucca PT; DiBattiste PM; Demopoulos LA; Weintraub WS; Braunwald E;
    JAMA; 2001 Nov; 286(19):2405-12. PubMed ID: 11712935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
    Damman P; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ;
    J Am Coll Cardiol; 2010 Mar; 55(9):858-64. PubMed ID: 20045278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
    Hirsch A; Windhausen F; Tijssen JG; Verheugt FW; Cornel JH; de Winter RJ;
    Lancet; 2007 Mar; 369(9564):827-835. PubMed ID: 17350451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
    Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
    Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators.
    Lagerqvist B; Säfström K; Ståhle E; Wallentin L; Swahn E;
    J Am Coll Cardiol; 2001 Jul; 38(1):41-8. PubMed ID: 11451294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of an early invasive management strategy in women with acute coronary syndromes.
    Glaser R; Herrmann HC; Murphy SA; Demopoulos LA; DiBattiste PM; Cannon CP; Braunwald E
    JAMA; 2002 Dec; 288(24):3124-9. PubMed ID: 12495392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute coronary syndromes: an update. II. Coronary revascularization and risk stratification].
    Auer J; Berent R; Maurer E; Mayr H; Weber T; Eber B
    Herz; 2001 Mar; 26(2):111-8. PubMed ID: 11349613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute management--how should we intervene?
    Kontny F
    Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I8-12. PubMed ID: 10680038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term low-molecular-weight heparin (Fragmin) and/or early revascularization during instability in coronary artery disease (the FRISC II Study).
    Wallentin L; Husted S; Kontny F; Swahn E
    Am J Cardiol; 1997 Sep; 80(5A):61E-63E. PubMed ID: 9296473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving outcomes in acute coronary syndromes--the FRISC II trial.
    Kontny F
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I3-7. PubMed ID: 11286312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction.
    Braunwald E
    Circulation; 2003 Oct; 108(16 Suppl 1):III28-37. PubMed ID: 14605017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndromes: extending medical intervention for five days before proceeding to revascularization.
    Holmes DR
    Am J Cardiol; 2000 Dec; 86(12B):36M-41M. PubMed ID: 11206017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes. Minireview based on a doctorial thesis.
    Lindahl B
    Ups J Med Sci; 1996; 101(3):193-232. PubMed ID: 9055387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.